[1]
matteo molica, “Sustained Remission in an Elderly Patient with Acute Myeloid Leukemia Following Gilteritinib Treatment as Third-Line Salvage Therapy: Long-lasting disease remission with third line therapy with gilteritinib”, Mediterr J Hematol Infect Dis, vol. 16, no. 1, p. e2024079, Oct. 2024.